| NCT Number | NCT03858322 |
| Lead Sponsor | Dana-Farber Cancer Institute
Collaborators: Mayo Clinic |
| Conditions | Breast Cancer |
| Enrollment | 41 participants |
| Start Date | 2019-03-21 |
| Primary Completion | 2020-11-10 (estimated) |
| Study Completion | 2026-12-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-13 |